Back To Schedule
Monday, September 19 • 8:45am - 9:15am
Keynote: Perseverance (and Innovation) Pay in Biotech

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

With a sharp decline in the XBI, the poor performance of recent IPOs and dwindling balance sheets at countless companies, these are challenging times in the biotech market. But they are not unprecedented. In this keynote address, Mersana Therapeutics CEO Anna Protopapas discusses the sector’s ups and downs and shares key insights and learnings from her two decades of leadership at Millennium Pharmaceuticals, Takeda and Mersana, a former Fierce 15 award winner.

avatar for Anna Protopapas

Anna Protopapas

President and Chief Executive Officer, Mersana Therapeutics
Anna joined Mersana in March 2015, bringing a substantial track record of executive leadership and business experience in the biotech industry. Prior to Mersana, Anna was President of Millennium, where she led Takeda Pharmaceutical Co.’s $1.3 billion oncology business. Anna also... Read More →

Monday September 19, 2022 8:45am - 9:15am EDT